NewEdge Advisors’s TuHURA Biosciences HURA Stock Holding History

NewEdge Advisors’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2	Hold	1	–	–	﹤0.01%	4179
2026 Q1	$2	Hold	1	–	–	﹤0.01%	4121
2025 Q4	$1	Hold	1	–	–	﹤0.01%	4202
2025 Q3	$2	Buy	+1	New	+$3	﹤0.01%	4091

Other funds holding HURA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

NewEdge Advisors's HURA Position: Q2 2026 in Review

NewEdge Advisors held its TuHURA Biosciences (HURA) position steady in Q2 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #4179.

NewEdge Advisors first reported a position in HURA in Q3 2025 and has held it in 4 quarters since. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

NewEdge Advisors held 1 share of TuHURA Biosciences worth $2 as of Q2 2026.
NewEdge Advisors left its TuHURA Biosciences share count unchanged in Q2 2026.
TuHURA Biosciences made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #4179 holding.
NewEdge Advisors first reported a position in TuHURA Biosciences in Q3 2025 and has held it in 4 quarters since.
89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.